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The present study was intended to evaluate the acute and short-term hemodynamic, angiographic, 
and pathological response to balloon-expandable stent treatment of experimental coarctation of the 
aorta. A discrete thoracic coarctation was surgically created in six mongrel dogs (two adults, four 
puppies). Two months postoperatively all six dogs (8.9-30 kg) underwent left heart catheterization and 
coarctation stenting performed through a femoral artery cutdown. A Palmaz PS-30 stent was advanced 
to the coarctation through a IOFrench sheath, and expanded with an angioplasty balloon chosen to 
equal the diameter of the proximaf aorta (9-12 mm). Sfent implantation was successful in each dog. 
The systolic pressure gradient decreased from 26.3 ? 9.1 mmHg (mean & SE) to 0.5 c 0.5 mmHg 
(P  = O M ) ,  and the coarctation diameter improved from 50 2 6% to 82 c 6% of the diameter of the 
proximal descending aorta (P  < 0.01). Follow-up catheterization 4-7 weeks after stenting documented 
no stent migration, early restenosis, thrombosis, obstruction of arterial side branches, or aneurysm 
formation. Pathological evaluation of the explanted segments of stented aorta documented that by 
6-7 weeks the stents are covered by a neointima composed of intimal proliferation and fibrosis with 
an endothelial cell surface. These data suggest that balloon-expandable stainless steel stents provide 
excellent acute and short-term relief of coarctation in this experimental model. Larger and longer- 
term studies are needed to better assess the incidence of restenosis or aneurysm formation following 
stenring of coarctation of the aorta. (J Interven Cardiol 1993; 6: 113-123) 
Introduction 
Conventional therapy for coarctation, either 
surgical repair or balloon angioplasty, may yield 
unsatisfactory results in some patients due to re- 
sidual or recurrent stenosis andfor late aneurysm 
formation.'-'O A balloon-expandable stainless 
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steel stent (serving as an endovascular prosthesis 
to support the aortic wall after dilation) offers 
theoretical advantages over current therapies. A 
stent will buttress the aortic wall after dilation, 
thereby preventing the elastic recoil which is 
often responsible for an unsuccessful balloon an- 
gioplasty procedure. Further, by tacking intimal 
flaps against the vessel wall," stent support may 
diminish the likelihood of late aneurysm forma- 
tion. The purpose of the present investigation was 
to evaluate the effectiveness of a balloon-expand- 
able stainless steel stent (the Palmaz PS30 stent 
Johnson & Johnson Interventional Systems, 
Warren, NJ, USA) in an experimental model of 
coarctation of the aorta. Specifically, we sought 
to determine if the stent can provide acute hemo- 
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dynamic and angiographic relief of experimental 
coarctation, without early restenosis, thrombo- 
sis, aneurysm formation, or obstruction to arte- 
rial side branches. Finally. the short-term gross 
and microscopic tissue response to stent treat- 
ment was evaluated. 
Methods 
A discrete thoracic coarctation of the aorta was 
surgically created in six mongrel dogs (two adults 
and four puppies) through a left lateral thoracot- 
omy performed under general anesthesia. The 
aorta was clamped proximally and distally be- 
yond the left subclavian artery, and an incision 
was made across SO% of the diameter of the aorta. 
The resulting V-shaped defect was closed with a 
continuous suture of 5-0 polypropylene. No tis- 
sue was resected. Eight to 10 weeks after creation 
of the coarctation, all six dogs (8.9-30 kg) under- 
went left heart catheterization and coarctation 
stenting under thiamylal sodium anesthesia. Arte- 
rial access was achieved by right femoral artery 
cutdown and systemic heparin (100 units/kg) was 
administered. The coarctation pressure gradient 
was measured by catheter withdrawal from as- 
cending to descending aorta, after which an as- 
cending aortogram was filmed in the left anterior 
oblique projection. A Palmaz PS30 stainless steel 
stent (3.4 x 30 mm) was mounted on an angio- 
plasty balloon whose diameter was chosen to 
equal the diameter of the normal aorta immedi- 
ately beyond the left subclavian artery (9-12 
mm). The stent was advanced through a IOFrench 
sheath (Cook Inc., Bloomington, l N ,  USA) to the 
site of coarctation. The sheath was withdrawn 
slightly and contrast was injected through the side 
arm to assure that the stent was properly centered 
on the coarctation. The angioplasty balloon was 
then inflated by hand, and the stent dilated until 
the waist created by the coarctation on the stent 
either resolved or markedly improved. Balloon 
inflation pressures were not measured during the 
procedure, and no balloon ruptures occurred. 
After stenting. the angioplasty catheter was with- 
drawn and a pigtail catheter was advanced to the 
ascending aorta over a 0.35 in. exchange guide- 
wire. A repeat aortogram was filmed, after which 
pressures were again recorded in the ascending 
and descending aorta. The sheath was removed 
from the femoral artery, and the arteriotomy was 
repaired. 
All six dogs recovered well and received no 
chronic anticoagulant or antiplatelet agents. One 
animal died an anesthetic death during an unre- 
lated procedure 6 weeks after stenting. In this 
animal (whose stent was widely patent) follow- 
up aortic diameter measurements were obtained 
from postmortem angiography of the specimen, 
but late hemodynamic data were not obtained. 
In  the remaining five dogs, a follow-up left heart 
catheterization was performed 4-7 weeks follow- 
ing stenting. The residual pressure gradient was 
measured prior to angiography by catheter with- 
drawal across the stented coarctation site, and an 
aortogram was filmed in the left anterior oblique 
projection. The animals were then sacrificed and 
the stented segment of aorta removed. Gross ex- 
amination of all six specimens was performed to 
determine the extent of neointima coverage, pa- 
tency of arterial side branches, and to detect evi- 
dence of thrombosis or aneurysm formation. The 
specimens were then fixed for microscopic evalu- 
ation. 
Data Analysis. All angiographic diameters were 
measured by caliper from the left anterior oblique 
aortogram. The coarctation diameters were ex- 
pressed as a ratio of the narrowest diameter over 
the diameter of the normal aorta proximal to the 
coarctation. Data are presented as mean * one 
standard error of the mean. Measures obtained 
before stenting, after stenting, and at follow-up 
are compared using a repeated measures analysis 
of variance. Pairwise comparisons are performed 
using the Scheffe test, with a P value of < 0.05 
required as evidence of a significant effect. The 
protocol was approved by the University of 
Michigan Committee on the Use and Care of An- 
imals. 
Results 
Hemodynamic Data. Prior to stenting, a wide 
range of coarctation severity was documented, 
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Figure 1. Systolic pressure gradient across the coarctation site before and immediately after stenting, 
and at 4-7 week follow-up study. 
with peak-to-peak systolic pressure gradients 
ranging from 8 mmHg to 63 mmHg. The stenting 
procedure provided acute relief of stenosis in all 
animals (Fig. 1). The systolic gradient decreased 
after stenting from 26.3 & 9.1 mmHg to 0.5 & 
0.5 mmHg (P < 0.05). At follow-up catheteriza- 
tion 4-7 weeks after stenting, there was no resid- 
ual systolic pressure gradient present in any ani- 
mal. Systolic pressure in the ascending aorta was 
185 t 22 mmHg immediately prior to stenting, 
176 ? 10 mmHg immediately after stenting, and 
170 ? 1 1  mmHg at follow-up (P = NS for all 
pairwise comparisons). 
Angiographic Data. The coarctation stenosis di- 
ameter, normalized as a percent of the proximal 
aortic diameter, increased in all animals after the 
stenting procedure (Figs. 2 and 3). The coarcta- 
tion diameter increased acutely from 50 t 6% to 
82 + 6% of the diameter of the proximal aorta 
(P < 0.01). There was no evidence of restenosis 
at follow-up 4-7 weeks later, as the coarctation 
diameters had not changed (87 ? 5%). All stents 
were widely patent and there was no evidence 
of stent movement or migration, thrombosis or 
aneurysm formation at the follow-up angio- 
graphic study. The intercostal arteries traversed 
by the stent remained angiographically patent, 
both immediately after stenting and at the follow- 
up study (Fig. 4). Due to the location of the coarc- 
tation, the stent did not cross the origin of the 
left subclavian artery in any animal. 
In two animals, the poststenotic descending 
aorta was noted to be substantially wider than the 
stent diameter immediately after stent implanta- 
tion. In one animal, this size discrepancy was ex- 
aggerated by suboptimal distal positioning of the 
stent relative to the coarctation. In both animals, 
the 6-week follow-up angiogram documented that 
the poststenotic aorta had remodeled to equal the 
stent diameter (Fig. 5 ) .  Aortic remodeling oc- 
curred without angiographic or pathological evi- 
dence of thrombosis or restenosis. 
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P R E  POST FOLLOW-UP 
Figure 2. Coarctation diameter (as percent of proximal aorta diameter) before and immediately after stenting, and at 4-7 week 
follow-up study. 
Figure 3a. Aortogram (left anterior oblique projection) showing a discrete coarctation in a 9. I-kg puppy. The pressure gradient 
was 63 mmHg. 
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Figure 3b. A Palmaz balloon-ex- 
pandable stent was dilated with 
a 9-mm balloon. 
Figure 3c. Repeat aortogram dem- 
onstrating improvement in the co- 
arctation (this is the most severe re- 
sidual stenosis observed in the 
entire study). There was no residual 
pressure gradient present. 
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Figure 1. Aortogram I left anterior oblique projection) 6 \\ eeks after coarctation stenting. demonstrating late patency of the 
intercostal arteries traversed bh the \tent. 
Pathological Data. Gros5 examination found all 
stented aortic segments to be widely patent. with- 
out evidence of thrombosis or aneurysm forma- 
tion. In the single specimen evaluated 4 weeks 
after stenting. a thin milky white neointima cov- 
ered approximately 50Cr ofthe stent. The remain- 
ing five specimens Mere evaluated 6-7 weeks 
after stenting and the neointima coverage was vir- 
tually complete in all. Neointima was absent only 
on small portions of stent5 overlying arterial side 
branches. Patent orifice.; of the intercostal arter- 
ies arising from the stented aorta were evident in 
all specimens (Fig. 6) .  
Microscopic evaluation revealed that the neo- 
intima on each stent consisted of an endothelial 
cell surface. covering a layer of intimal prolifera- 
tion (4-6 week specimens) or fibrosis (6-7 week 
specimens). Localized \hallow areas of medial 
necrosis were found immediately beneath several 
stent wires (Fig. 7). Small patches of medial calci- 
fication were noted in two specimens, and a 
larger medial calcification noted in one. Arterial 
side branches arising from the stented aortic seg- 
ments were patent (Fig. 8). 
Discussion 
Coarctation of the aorta affects approximately 
8%- 10% of children with congenital heart dis- 
ease. The goal of therapy is to relieve the hemo- 
dynamic and anatomical stenosis, without early 
or late restenosis and without aneurysm forma- 
tion at the site of repair. Current methods of treat- 
ment have had mixed results. Residual or  recur- 
rent stenosis, as well as late aneurysm formation, 
have been well-described following either surgery 
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Figure 5a. Aortogram (left ante- 
rior oblique projection) showing a 
discrete coarctation in a 10.9-kg 
puppy. The pressure gradient was 
42 mmHg. 
Figure 5b. Immediately after 
stenting, the stent is noted to be 
poorly centered on the coarctation 
with a distal diameter substan- 
tially smaller than the diameter of 
the poststenotic aorta. 
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Figure 5c. Aortogram of same animal 6 weeks later, demonstrating that the poststenotic aorta had 
remodeled to now equal the diameter of the stent. There was no residual gradient or evidence of throm- 
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or balloon angioplasty. ' - l o  The experience with 
angioplasty , however, has provided the rationale 
for attempting stent treatment of coarctation. An- 
gioplasty alone fails to provide adequate gradient 
relief in approximately 20%-25% of patients, 
often due to the elastic nature of the lesion. In 
many patients the coarctation tissue dilates as the 
angioplasty balloon is inflated. but recoils imme- 
diately upon balloon deflation. The use of a stain- 
less steel stent, to buttress the aortic wall after 
dilation, therefore holds a theoretical advantage 
over naked balloon angioplasty for treatment of 
coarctation. Stent treatment offers a promising 
nonsurgical alternative to conventional treatment 
strategies which may diminish the likelihood of 
residual stenosis and aneurysm formation at the 
site of coarctation repair. 
The current investigation has provided prelimi- 
nary data confirming the potential effectiveness 
of stent treatment for coarctation of the aorta. In 
an experimental coarctation model, the Palmaz 
balloon-expandable stainless steel stent has been 
shown to provide acute hemodynamic and angio- 
graphic relief of coarctation stenosis. Short-term 
follow-up evaluation (4-7 weeks) found no evi- 
dence of early restenosis, thrombosis, aneurysm 
formation, or obstruction to arterial side 
branches. In two dogs, the poststenotic aorta was 
found to undergo early remodeling to match the 
diameter of the stent. Within 6-7 weeks all stents 
were covered by a neointima composed of intimal 
proliferation and fibrosis with an endothelial cell 
surface. Extensive medial changes were un- 
common. 
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Figure 6. Gross specimen 7 weeks after coarctation stenting. Neointimal coverage is nearly complete, with no evidence of 
thrombosis or aneurysm. The patent orifices of several intercostal arteries are evident. 
Previous Studies of Arterial Stenting. Balloon- 
expandable stent treatment of systemic arterial 
stenoses has been evaluated previously in animal 
and human studies."-16 The Palmaz stainless 
steel stent was developed specifically to provide 
transcatheter relief of vascular stenoses, and its 
effects have been extensively evaluated including 
after placement in the aortic position. For exam- 
ple, Palmaz and colleagues evaluated the stent in 
the aortas of 24 atherosclerotic rabbits.12 Patho- 
logical evaluation 1-24 weeks after stent place- 
ment documented persistent patency without ste- 
nosis. Subsequently, clinical trials have evalu- 
ated stents in patients with coronary or peripheral 
artery ~ tenos i s , ' ~ - '~  as well as in children with 
pulmonary artery stenosis." Although late reste- 
nosis has been documented in some coronary ar- 
teries, restenosis occurs less commonly when 
stents are placed in larger arteries such as the 
iliac or pulmonary arteries. There are very few 
data regarding the use of stents to treat coarcta- 
tion of the aorta, however. In an abstract, Mor- 
row and colleagues presented their experience 
using balloon-expandable stents to treat an exper- 
imental coarctation in seven swine. l 8  Stenting de- 
creased the systolic coarctation gradient from 26 
mmHg to 1 mmHg, but histologic data were not 
reported. Finally, O'Laughlin et al. have reported 
one patient with coarctation in whom a stent was 
implanted after unsuccessful balloon angio- 
plasty. " 
Limitations of the Present Study. Several limita- 
tions of the present study must be acknowledged. 
First, the small number of animals limits the in- 
vestigation's power to detect a significant inci- 
dence of restenosis or aneurysm formation. Lim- 
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Figure 7. Section of stented aorta showing site of stent wire ( S )  with underlying focal medial necrosis and hemosiderin pigment. 
The “neointima” above the stent consists of intimal proliferation and fibrosis with a surface endothelium. (H and E x 63.) 
Figure 8. The origin of a patent intercostal artery is seen arising adjacent to (and between) stent wire ( S )  sites. ( H  and E x 29.) 
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ited statistical power also explains our inability 
to detect a significant change in ascending aorta 
pressure after stenting. Second, the 4-7 week fol- 
low-up duration is short. Previous studies of cor- 
onary artery stents have suggested that neointi- 
ma1 proliferation has not reached its maximum 
level until approximately 3-6 months after stent- 
ing.I6 Third, this study does not provide data re- 
garding patency of the left subclavian artery if a 
stent covers it's origin since, in all animals, the 
stent was positioned distal to the subclavian ar- 
tery. Previous studies have shown that large cor- 
onary artery and pulmonary artery side branches 
remain patent when crossed by a ~ t e n t , ' ~ - ' ~ - ' ' a n d  
we therefore speculate that flow to the left subcla- 
vian artery will not be compromised if a stent 
crosses it's origin. Finally, the experimental 
model of coarctation evaluated in this study may 
not relate well to native (unoperated) human co- 
arctation. It may be more representative of post- 
operative recurrent coarctation (i.e., after prior 
surgical repair). Since an animal model of native 
coarctation is not available, it remains to be de- 
termined if balloon-expandable stents can be 
used to effectively treat native lesions. The expe- 
rience that many native coarctations dilate during 
balloon angioplasty only to recoil upon balloon 
deflation, however, suggests that stents may suc- 
ceed in treating native coarctations as well. 
Conclusions 
The current investigation has provided prelimi- 
nary data indicating that balloon-expandable 
stents can be used successfully to treat an experi- 
mental model of coarctation of the aorta. In six 
animals, the Palmaz stainless steel stent provided 
effective relief of hemodynamic and angiographic 
stenosis without early restenosis, thrombosis, or 
aneurysm formation. Additional studies are nec- 
essary, with a larger number of animals and a 
longer follow-up duration, to better determine the 
risks of restenosis or aneurysm formation follow- 
ing coarctation stenting. Further, since human 
coarctation is best treated in childhood, studies 
are needed to determine if a stent implanted to 
treat coarctation in a growing animal can be 
safely redilated to a larger diameter after the ani- 
mal has grown. 
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